Victory Capital Management
NUTX

Victory Capital Management’s Nutex Health NUTX Stock Holding History

Victory Capital Management’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.99M Sell
29,190
-15,944
-35% -$2.02M ﹤0.01% 1366
2026
Q1 		$4.29M Buy
45,134
+30,650
+212% +$3.76M ﹤0.01% 1374
2025
Q4 		$2.38M Sell
14,484
-1,852
-11% -$246K ﹤0.01% 1537
2025
Q3 		$1.69M Buy
16,336
+9,112
+126% +$893K ﹤0.01% 1648
2025
Q2 		$899K Buy
+7,224
New +$933K ﹤0.01% 1894
2024
Q2 		– Sell
-334
Closed -$4.8K – 2518
2024
Q1 		$4.8K Buy
334
+19
+6% +$382 ﹤0.01% 2468
2023
Q4 		$8.5K Buy
315
+68
+28% +$2.12K ﹤0.01% 2532
2023
Q3 		$7.51K Buy
247
+24
+11% +$1.16K ﹤0.01% 2493
2023
Q2 		$14.1K Sell
223
-5
-2% -$429 ﹤0.01% 2471
2023
Q1 		$34.6K Sell
228
-3
-1% -$608 ﹤0.01% 2473
2022
Q4 		$65.9K Hold
231
– – ﹤0.01% 2416
2022
Q3 		$52K Sell
231
-65
-22% -$27.6K ﹤0.01% 2559
2022
Q2 		$143K Buy
+296
New +$349K ﹤0.01% 2413

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Victory Capital Management's NUTX Position: Q2 2026 in Review

Victory Capital Management reduced its Nutex Health (NUTX) stake by 35% in Q2 2026, selling an estimated $2.02M and leaving 29,190 shares worth $4.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

Victory Capital Management first reported a position in NUTX in Q2 2022 and has held it in 13 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Victory Capital Management held 29,190 shares of Nutex Health worth $4.99M as of Q2 2026.
  • Victory Capital Management sold 15,944 Nutex Health shares in Q2 2026, an estimated $2.02M.
  • Nutex Health made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1366 holding.
  • Victory Capital Management first reported a position in Nutex Health in Q2 2022 and has held it in 13 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.